Hm. Ockenfels et al., INHIBITION OF T-CELL CAMP FORMATION BY CYCLOSPORINE-A AND FH506, Naunyn-Schmiedeberg's archives of pharmacology, 353(5), 1996, pp. 513-516
The influence of the immunosuppressants, cyclosporin A (CsA) and FK506
, on cAMP formation was studied in T cells from healthy controls and p
atients with psoriasis. While basal cAMP levels were not affected, CsA
(1 mu M) and FK506 (2 nM) prevented the isoprenaline (0.1 mu M)-induc
ed increase in cAMP formation. Half-maximal inhibition by FK506 and Cs
A was observed at about 0.2 nM and 20 nM, respectively. In addition, b
oth agents significantly reduced (by about 50%) the forskolin 8 mu M)-
stimulated cAMP formation. No differences were noted in cAMP responses
(basal, stimulation by isoprenaline, inhibition by CsA and FK506) of
T cells from healthy controls and psoriatic patients. We conclude that
CsA and FK506 potently and efficiently interfere with the stimulatory
adenylyl cyclase pathway in T cells and that regulation of T cell cAM
P formation is apparently not altered in psoriasis.